RBOT
Vicarious Surgical Inc.
NYSE · Healthcare · Medical - Devices · US
$0.01
+0.91%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$0.01
From 52W high−99.76%
Volume23523.00
Market cap$65914.93
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataNov 4, 2026
Open
$0.01
From 52W high
−99.76%
Volume
23523.00
Market cap
$65914.93
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
P/E (TTM)
—
RSI (14)
44.6
MomentumView details →
1D Return
+0.91%
YTD Return
−99.49%
SummaryUpdated Mar 1, 2026
Vicarious Surgical Inc. (NYSE:RBOT) is a medical device company founded in 2014 and headquartered in Waltham, Massachusetts. The company went public through a SPAC merger in September 2020. Vicarious Surgical is developing revolutionary single-incision surgical robotics technology that aims to transform minimally invasive surgery by virtually transporting surgeons inside the patient's body. The company is currently in the pre-commercial stage, having completed development of its Version 1.0 surgical system and preparing for its first clinical trials in 2025.
Similar companies
Latest newsMore news →
Vicarious Surgical shareholders voted to shut down and liquidate the company immediately.106d agoVicarious Surgical's board of directors proposes to dissolve and liquidate the company, seeking shareholder approval at a special meeting on July 21, 2026.112d agoSarah Romano resigned as Chief Financial Officer of Vicarious Surgical Inc., effective July 22, 2026.134d ago